A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA

BACKGROUND: Preclinical studies have shown that the novel isoxazoline, lotilaner (Credelio™, Elanco) administered orally to dogs, produces rapid flea and tick knockdown and sustained speed of kill for at least a month post-treatment with a wide safety margin. A field study was undertaken to validate...

Descripción completa

Detalles Bibliográficos
Autores principales: Karadzovska, Daniela, Chappell, Kimberly, Coble, Shane, Murphy, Martin, Cavalleri, Daniela, Wiseman, Scott, Drake, Jason, Nanchen, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664423/
https://www.ncbi.nlm.nih.gov/pubmed/29089063
http://dx.doi.org/10.1186/s13071-017-2469-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664423/
https://www.ncbi.nlm.nih.gov/pubmed/29089063
http://dx.doi.org/10.1186/s13071-017-2469-x

Ejemplares similares